Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Nakazawa, I; Nakajima, T; Ishigami, T; Umemura, S; Emi, M
   Linkage disequilibrium and haplotype analysis among eight novel single-nucleotide polymorphisms in the human tissue-type plasminogen activator (t-PA)gene
   JOURNAL OF HUMAN GENETICS
   
   I. Nakazawa et al., "Linkage disequilibrium and haplotype analysis among eight novel single-nucleotide polymorphisms in the human tissue-type plasminogen activator (t-PA)gene", J HUM GENET, 46(7), 2001, pp. 367-371
2. Toss, H; Wallentin, L; Siegbahn, A
   Effects of low-molecular-weight heparin treatment on fibrinolytic markers in unstable coronary artery disease
   FIBRINOLYSIS & PROTEOLYSIS
   
   H. Toss et al., "Effects of low-molecular-weight heparin treatment on fibrinolytic markers in unstable coronary artery disease", FIBRINOL PR, 15(1), 2001, pp. 26-31
3. Vermeulen, LC; Davis, SN; Schwartz, BS
   Alteplase activity
   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
   
   L.C. Vermeulen et al., "Alteplase activity", AM J HEAL S, 58(7), 2001, pp. 617-617
4. Watanabe, R; Wada, H; Miura, Y; Murata, Y; Watanabe, Y; Sakakura, M; Okugawa, Y; Nakasaki, T; Mori, Y; Nishikawa, M; Gabazza, EC; Shiku, H; Nobori, T
   Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura
   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
   
   R. Watanabe et al., "Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura", CL APPL T-H, 7(3), 2001, pp. 229-233
5. Koh, SCL; Tham, KF; Razvi, K; Oei, PL; Lim, FK; Roy, AC; Prasad, RNV
   Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included asprognostic markers for survival outcome?
   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
   
   S.C.L. Koh et al., "Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included asprognostic markers for survival outcome?", CL APPL T-H, 7(2), 2001, pp. 141-148
6. Sumii, T; Singhal, AB; Asahi, M; Shimizu-Sasamata, M; Suzuki, M; Miyata, K; Lo, EH
   Protective effects of pamiteplase, a modified t-PA, in a rat model of embolic stroke
   NEUROREPORT
   
   T. Sumii et al., "Protective effects of pamiteplase, a modified t-PA, in a rat model of embolic stroke", NEUROREPORT, 12(3), 2001, pp. 615-618
7. Olivotti, L; Spallarossa, P; Piana, A; Iannone, A; Rossettin, P; Ghigliotti, G; Armani, U; Barsotti, A; Brunelli, C
   Maximal endothelial tissue plasminogen activator release is not impaired in patients with acute coronary syndromes before heparin treatment
   BLOOD COAGULATION & FIBRINOLYSIS
   
   L. Olivotti et al., "Maximal endothelial tissue plasminogen activator release is not impaired in patients with acute coronary syndromes before heparin treatment", BL COAG FIB, 12(4), 2001, pp. 261-267
8. Stief, TW; Kretschmer, V; Kosche, B; Doss, MO; Renz, H
   Thrombin converts singlet oxygen (O-1(2))-oxidized fibrinogen into a soluble t-PA cofactor - A new method for preparing a stimulator for functional t-PA assays
   ANNALS OF HEMATOLOGY
   
   T.W. Stief et al., "Thrombin converts singlet oxygen (O-1(2))-oxidized fibrinogen into a soluble t-PA cofactor - A new method for preparing a stimulator for functional t-PA assays", ANN HEMATOL, 80(4), 2001, pp. 189-194
9. Huber, K
   Plasminogen activator inhibitor type-1 (part two): Role for failure of thrombolytic therapy. PAI-1 resistance as a potential benefit for new fibrinolytic agents
   JOURNAL OF THROMBOSIS AND THROMBOLYSIS
   
   K. Huber, "Plasminogen activator inhibitor type-1 (part two): Role for failure of thrombolytic therapy. PAI-1 resistance as a potential benefit for new fibrinolytic agents", J THROMB TH, 11(3), 2001, pp. 195-202
10. Aoki, S; Shimizu, N; Shimonishi, M; Kitagawa, M; Okumura, K; Tanigawara, Y
    Influence of sugar chain on fibrin affinity of recombinant t-PA
    BIOLOGICAL & PHARMACEUTICAL BULLETIN
    
    S. Aoki et al., "Influence of sugar chain on fibrin affinity of recombinant t-PA", BIOL PHAR B, 24(3), 2001, pp. 295-298
11. Gladstone, DJ; Black, SE
    Update on intravenous tissue plasminogen activator for acute stroke: from clinical trials to clinical practice
    CANADIAN MEDICAL ASSOCIATION JOURNAL
    
    D.J. Gladstone e S.E. Black, "Update on intravenous tissue plasminogen activator for acute stroke: from clinical trials to clinical practice", CAN MED A J, 165(3), 2001, pp. 311-317
12. Aoki, S; Kitagawa, M; Okumura, K
    Pharmacokinetic studies of Gln117 tissue-type plasminogen activator in rats
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    
    S. Aoki et al., "Pharmacokinetic studies of Gln117 tissue-type plasminogen activator in rats", J PHARM B, 26(3), 2001, pp. 453-462
13. Magnusson, C; Hogklint, L; Libelius, R; Tagerud, S
    Expression of mRNA for plasminogen activators and protease nexin-1 in innervated and denervated mouse skeletal muscle
    JOURNAL OF NEUROSCIENCE RESEARCH
    
    C. Magnusson et al., "Expression of mRNA for plasminogen activators and protease nexin-1 in innervated and denervated mouse skeletal muscle", J NEUROSC R, 66(3), 2001, pp. 457-463
14. Raaphorst, J; Groeneveld, ABJ; Bossink, AWJ; Hack, CE
    Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients
    THROMBOSIS AND HAEMOSTASIS
    
    J. Raaphorst et al., "Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients", THROMB HAEM, 86(2), 2001, pp. 543-549
15. Paramo, JA; Orbe, J; Fernandez, J
    Fibrinolysis/proteolysis balance in stable angina pectoris in relation to angiographic findings
    THROMBOSIS AND HAEMOSTASIS
    
    J.A. Paramo et al., "Fibrinolysis/proteolysis balance in stable angina pectoris in relation to angiographic findings", THROMB HAEM, 86(2), 2001, pp. 636-639
16. Hill, MD; Buchan, AM
    Methodology for the Canadian Activase For Stroke Effectiveness Study (CASES)
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
    
    M.D. Hill e A.M. Buchan, "Methodology for the Canadian Activase For Stroke Effectiveness Study (CASES)", CAN J NEUR, 28(3), 2001, pp. 232-238
17. Dominguez, M; Cacoub, P; de la Torre, IG; Piette, JC; Salazar-Paramo, M; Godeau, P; Angles-Cano, E
    Autoantibodies to receptor induced neoepitopes of fibrinolytic proteins inrheumatic and vascular diseases
    JOURNAL OF RHEUMATOLOGY
    
    M. Dominguez et al., "Autoantibodies to receptor induced neoepitopes of fibrinolytic proteins inrheumatic and vascular diseases", J RHEUMATOL, 28(2), 2001, pp. 302-308
18. Aoki, K; Aikawa, N; Sekine, K; Yamazaki, M; Mimura, T; Urano, T; Takada, A
    Elevation of plasma free PAI-1 levels as an integrated endothelial response to severe burns
    BURNS
    
    K. Aoki et al., "Elevation of plasma free PAI-1 levels as an integrated endothelial response to severe burns", BURNS, 27(6), 2001, pp. 569-575
19. Petik, AV; Platonova, TN; Andrianov, SI; Pyaskovskaya, ON; Savchuk, AN; Lukinova, NI; Yakovlev, SA; Chekhun, VF
    Some indices of haemostasis during Lewis lung carcinoma growth
    EXPERIMENTAL ONCOLOGY
    
    A.V. Petik et al., "Some indices of haemostasis during Lewis lung carcinoma growth", EXP ONCOL, 23(1), 2001, pp. 73-75
20. Liang, JF; Park, YJ; Song, H; Li, YT; Yang, VCM
    ATTEMPTS: A heparin/protamine-based prodrug approach for delivery of thrombolytic drugs
    JOURNAL OF CONTROLLED RELEASE
    
    J.F. Liang et al., "ATTEMPTS: A heparin/protamine-based prodrug approach for delivery of thrombolytic drugs", J CONTR REL, 72(1-3), 2001, pp. 145-156
21. Gibson, CM; Marble, SJ
    Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA)
    CLINICAL CARDIOLOGY
    
    C.M. Gibson e S.J. Marble, "Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA)", CLIN CARD, 24(9), 2001, pp. 577-584
22. Abou-Agag, LH; Tabengwa, EM; Tresnak, JA; Wheeler, CG; Taylor, KB; Booyse, FM
    Ethanol-induced increased surface-localized fibrinolytic activity in cultured human endothelial cells: Kinetic analysis
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    
    L.H. Abou-Agag et al., "Ethanol-induced increased surface-localized fibrinolytic activity in cultured human endothelial cells: Kinetic analysis", ALC CLIN EX, 25(3), 2001, pp. 351-361
23. Labinjoh, C; Newby, DE; Wilkinson, IB; Megson, IL; MacCallum, H; Melville, V; Boon, NA; Webb, DJ
    Effects of acute methionine loading and vitamin C on endogenous fibrinolysis, endothelium-dependent vasomotion and platelet aggregation
    CLINICAL SCIENCE
    
    C. Labinjoh et al., "Effects of acute methionine loading and vitamin C on endogenous fibrinolysis, endothelium-dependent vasomotion and platelet aggregation", CLIN SCI, 100(2), 2001, pp. 127-135
24. Llevadot, J; Giugliano, RP; Antman, EM
    Bolus fibrinolytic therapy in acute myocardial infarction
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    
    J. Llevadot et al., "Bolus fibrinolytic therapy in acute myocardial infarction", J AM MED A, 286(4), 2001, pp. 442-449
25. Asakura, H; Ontachi, Y; Mizutani, T; Kato, M; Saito, M; Kumabashiri, I; Morishita, E; Yamazaki, M; Aoshima, K; Nakao, S
    An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation
    CRITICAL CARE MEDICINE
    
    H. Asakura et al., "An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation", CRIT CARE M, 29(6), 2001, pp. 1164-1168
26. Noguchi, T; Matsuyama, S; Akao, M; Hagiwara, H; Uno, S; Seki, T; Ariga, T
    Induction of hepatic tissue-type plasminogen activator and type 1 plasminogen activator-inhibitor gene expressions and appearance of their translation products in the bile following acute liver injury in rats
    THROMBOSIS RESEARCH
    
    T. Noguchi et al., "Induction of hepatic tissue-type plasminogen activator and type 1 plasminogen activator-inhibitor gene expressions and appearance of their translation products in the bile following acute liver injury in rats", THROMB RES, 104(4), 2001, pp. 283-291
27. Jansen, JWCM; van den Brink, H; Hoogenboom, PH
    Method to measure in vivo blood fibrinolytic activity with a I-125-fibrin coated aorta loop validated with agents which affect blood fibrinolytic activity
    THROMBOSIS RESEARCH
    
    J.W.C.M. Jansen et al., "Method to measure in vivo blood fibrinolytic activity with a I-125-fibrin coated aorta loop validated with agents which affect blood fibrinolytic activity", THROMB RES, 104(3), 2001, pp. 223-232
28. Nowak-Gottl, U; Kotthoff, S; Hagemeyer, E; Junker, R; Kehl, HG; Vielhaber, H; Kececioglu, D
    Interaction of fibrinolysis and prothrombotic risk factors in neonates, infants and children with and without thromboembolism and underlying cardiac disease - A prospective study
    THROMBOSIS RESEARCH
    
    U. Nowak-Gottl et al., "Interaction of fibrinolysis and prothrombotic risk factors in neonates, infants and children with and without thromboembolism and underlying cardiac disease - A prospective study", THROMB RES, 103(2), 2001, pp. 93-101
29. Oikawa, K; Kamimura, H; Watanabe, T; Miyamoto, I; Higuchi, S
    Pharmacokinetic properties of a novel tissue-type plasminogen activator pamiteplase after single intravenous administration to rats, dogs, and monkeys
    THROMBOSIS RESEARCH
    
    K. Oikawa et al., "Pharmacokinetic properties of a novel tissue-type plasminogen activator pamiteplase after single intravenous administration to rats, dogs, and monkeys", THROMB RES, 101(6), 2001, pp. 493-500
30. Reed, SD; Cramer, SC; Blough, DK; Meyer, K; Jarvik, JG
    Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals
    STROKE
    
    S.D. Reed et al., "Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals", STROKE, 32(8), 2001, pp. 1832-1839
31. Koennecke, HC; Nohr, R; Leistner, S; Marx, P
    Intravenous tPA for ischemic stroke team performance over time, safety, and efficacy in a single-center, 2-year experience
    STROKE
    
    H.C. Koennecke et al., "Intravenous tPA for ischemic stroke team performance over time, safety, and efficacy in a single-center, 2-year experience", STROKE, 32(5), 2001, pp. 1074-1078
32. Tjarnstrom, J; Holmdahl, L; Falk, P; Falkenberg, M; Arnell, P; Risberg, B
    Effects of hyperbaric oxygen on expression of fibrinolytic factors of human endothelium in a simulated ischaemia/reperfusion situation
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    
    J. Tjarnstrom et al., "Effects of hyperbaric oxygen on expression of fibrinolytic factors of human endothelium in a simulated ischaemia/reperfusion situation", SC J CL INV, 61(7), 2001, pp. 539-545
33. Choi, KS; Fitzpatrick, SL; Filipenko, NR; Fogg, DK; Kassam, G; Magliocco, AM; Waisman, DM
    Regulation of plasmin-dependent fibrin clot lysis by annexin II heterotetramer
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    K.S. Choi et al., "Regulation of plasmin-dependent fibrin clot lysis by annexin II heterotetramer", J BIOL CHEM, 276(27), 2001, pp. 25212-25221
34. Landriscina, M; Soldi, R; Bagala, C; Micucci, I; Bellum, S; Tarantini, F; Prudovsky, I; Maciag, T
    S100A13 participates in the release of fibroblast growth factor 1 in response to heat shock in vitro
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    M. Landriscina et al., "S100A13 participates in the release of fibroblast growth factor 1 in response to heat shock in vitro", J BIOL CHEM, 276(25), 2001, pp. 22544-22552
35. Costa, M; Medcalf, RL
    Ectopic expression of the cAMP-responsive element binding protein inhibitsphorbol ester-mediated induction of tissue-type plasminogen activator geneexpression
    EUROPEAN JOURNAL OF BIOCHEMISTRY
    
    M. Costa e R.L. Medcalf, "Ectopic expression of the cAMP-responsive element binding protein inhibitsphorbol ester-mediated induction of tissue-type plasminogen activator geneexpression", EUR J BIOCH, 268(4), 2001, pp. 987-996
36. Armstrong, PW; Collen, D
    Fibrinolysis for acute myocardial infarction - Current status and new horizons for pharmacological reperfusion, Part 1
    CIRCULATION
    
    P.W. Armstrong e D. Collen, "Fibrinolysis for acute myocardial infarction - Current status and new horizons for pharmacological reperfusion, Part 1", CIRCULATION, 103(23), 2001, pp. 2862-2866
37. Nicholls, SC; Chandler, WL; Hoffer, EK
    Thrombolysis failure: A role for plasminogen activator inhibitor type 1 (PAI-1)
    BRITISH JOURNAL OF HAEMATOLOGY
    
    S.C. Nicholls et al., "Thrombolysis failure: A role for plasminogen activator inhibitor type 1 (PAI-1)", BR J HAEM, 113(2), 2001, pp. 559-560
38. Wiebe, MG; Karandikar, A; Robson, GD; Trinci, APJ; Candia, JLF; Trappe, S; Wallis, G; Rinas, U; Derkx, PMF; Madrid, SM; Sisniega, H; Faus, I; Montijn, R; van den Hondel, CAMJJ; Punt, PJ
    Production of tissue plasminogen activator (t-PA) in Aspergillus niger
    BIOTECHNOLOGY AND BIOENGINEERING
    
    M.G. Wiebe et al., "Production of tissue plasminogen activator (t-PA) in Aspergillus niger", BIOTECH BIO, 76(2), 2001, pp. 164-174
39. Dowd, JE; Kwok, KE; Piret, JM
    Glucose-based optimization of CHO-cell perfusion cultures
    BIOTECHNOLOGY AND BIOENGINEERING
    
    J.E. Dowd et al., "Glucose-based optimization of CHO-cell perfusion cultures", BIOTECH BIO, 75(2), 2001, pp. 252-256
40. Werner, RG
    Improving natural principles with genetic engineering: TNK-tissue plasminogen activator
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    
    R.G. Werner, "Improving natural principles with genetic engineering: TNK-tissue plasminogen activator", ARZNEI-FOR, 51(6), 2001, pp. 516-520
41. Sanchez, MC; Chiabrando, GA; Vides, MA
    Pregnancy zone protein-tissue-type plasminogen activator complexes bind tolow-density lipoprotein receptor-related protein (LRP)
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    
    M.C. Sanchez et al., "Pregnancy zone protein-tissue-type plasminogen activator complexes bind tolow-density lipoprotein receptor-related protein (LRP)", ARCH BIOCH, 389(2), 2001, pp. 218-222
42. Vaughan, DE
    Angiotensin, fibrinolysis, and vascular homeostasis
    AMERICAN JOURNAL OF CARDIOLOGY
    
    D.E. Vaughan, "Angiotensin, fibrinolysis, and vascular homeostasis", AM J CARD, 87(8A), 2001, pp. 18C-24C
43. Ross, AM; Gao, RL; Coyne, KS; Chen, JL; Yao, KB; Yang, YJ; Qin, XW; Qiao, SB; Yao, M
    A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population anddemonstrating superiority to usual dose urokinase: The TUCC trial
    AMERICAN HEART JOURNAL
    
    A.M. Ross et al., "A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population anddemonstrating superiority to usual dose urokinase: The TUCC trial", AM HEART J, 142(2), 2001, pp. 244-247
44. Andronicos, NM; Baker, MS; Lackmann, M; Ranson, M
    Deconstructing the interaction of glu-plasminogen with its receptor alpha-enolase
    FIBRINOLYSIS & PROTEOLYSIS
    
    N.M. Andronicos et al., "Deconstructing the interaction of glu-plasminogen with its receptor alpha-enolase", FIBRINOL PR, 14(6), 2000, pp. 327-336
45. Prisco, D; Fedi, S; Brunelli, T; Chiarugi, L; Gianni, R; Santoro, E; Cappelletti, C; Pepe, G; Gensini, GF; Abbate, R
    Fibrinolytic parameters in young adults: the Floren-teen (Florence Teenager) Study
    FIBRINOLYSIS & PROTEOLYSIS
    
    D. Prisco et al., "Fibrinolytic parameters in young adults: the Floren-teen (Florence Teenager) Study", FIBRINOL PR, 14(5), 2000, pp. 275-280
46. Petersen, KR; Jorgensen, M; Vinberg, N; Gram, J; Skouby, SO; Tonnesen, KH; Jespersen, J
    Decreased synthesis of tissue plasminogen activator antigen in users of oral contraceptives
    FIBRINOLYSIS & PROTEOLYSIS
    
    K.R. Petersen et al., "Decreased synthesis of tissue plasminogen activator antigen in users of oral contraceptives", FIBRINOL PR, 14(5), 2000, pp. 315-321
47. Manhem, K; Dotevall, A; Wilhelmsen, L; Jern, S
    Preserved tissue-type plasminogen activator release and endothelium-dependent vasodilation in postmenopausal women with NIDDM
    JOURNAL OF DIABETES AND ITS COMPLICATIONS
    
    K. Manhem et al., "Preserved tissue-type plasminogen activator release and endothelium-dependent vasodilation in postmenopausal women with NIDDM", J DIABET C, 14(3), 2000, pp. 127-134
48. Semba, CP; Murphy, TP; Bakal, CW; Calis, KA; Matalon, TAS
    Thrombolytic therapy with use of alteplase (rt-PA) in peripheral arterial occlusive disease: Review of the clinical literature
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
    
    C.P. Semba et al., "Thrombolytic therapy with use of alteplase (rt-PA) in peripheral arterial occlusive disease: Review of the clinical literature", J VAS INT R, 11(2), 2000, pp. 149-161
49. Gurewich, V
    Fibrinolysis: an unfinished agenda
    BLOOD COAGULATION & FIBRINOLYSIS
    
    V. Gurewich, "Fibrinolysis: an unfinished agenda", BL COAG FIB, 11(5), 2000, pp. 401-408
50. Hunter, KA; Crosbie, LC; Weir, A; Miller, GJ; Dutta-Roy, AK
    A residential study comparing the effects of diets rich in stearic acid, oleic acid, and linoleic acid on fasting blood lipids, hemostatic variables and platelets in young healthy men
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY
    
    K.A. Hunter et al., "A residential study comparing the effects of diets rich in stearic acid, oleic acid, and linoleic acid on fasting blood lipids, hemostatic variables and platelets in young healthy men", J NUTR BIOC, 11(7-8), 2000, pp. 408-416
51. Sherman, DL
    Exercise and endothelial function
    CORONARY ARTERY DISEASE
    
    D.L. Sherman, "Exercise and endothelial function", CORON ART D, 11(2), 2000, pp. 117-122
52. Koenig, W; Ernst, E
    Exercise and thrombosis
    CORONARY ARTERY DISEASE
    
    W. Koenig e E. Ernst, "Exercise and thrombosis", CORON ART D, 11(2), 2000, pp. 123-127
53. Aoki, S; Shimizu, N; Koyama, J; Kato, Y; Kitagawa, M; Okumura, K; Tanigawara, Y
    Influence of N-terminal peptide and oligosaccharide on the clearance of t-PA
    BIOLOGICAL & PHARMACEUTICAL BULLETIN
    
    S. Aoki et al., "Influence of N-terminal peptide and oligosaccharide on the clearance of t-PA", BIOL PHAR B, 23(4), 2000, pp. 477-481
54. Folsom, AR
    Fibrinolytic factors and atherothrombotic events: epidemiological evidence
    ANNALS OF MEDICINE
    
    A.R. Folsom, "Fibrinolytic factors and atherothrombotic events: epidemiological evidence", ANN MED, 32, 2000, pp. 85-91
55. Engelstein, E; Margulies, J; Jeret, JS
    Lack of t-PA use for acute ischemic stroke in a community hospital: High incidence of exclusion criteria
    AMERICAN JOURNAL OF EMERGENCY MEDICINE
    
    E. Engelstein et al., "Lack of t-PA use for acute ischemic stroke in a community hospital: High incidence of exclusion criteria", AM J EMER M, 18(3), 2000, pp. 257-260
56. Lottermoser, K; Hertfelder, HJ; Vetter, H; Dusing, R
    Renin-angiotensin-aldosterone system and fibrinolysis
    MEDIZINISCHE KLINIK
    
    K. Lottermoser et al., "Renin-angiotensin-aldosterone system and fibrinolysis", MED KLIN, 95(12), 2000, pp. 683-688
57. Muneer, E; Bell, J; Doctor, VM
    Mechanism of enhancement by fucoidan and CNBr-fibrinogen digest of the activation of glu-plasminogen by tissue plasminogen activator
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
    
    E. Muneer et al., "Mechanism of enhancement by fucoidan and CNBr-fibrinogen digest of the activation of glu-plasminogen by tissue plasminogen activator", EUR J DRUG, 25(2), 2000, pp. 137-143
58. Linenberger, ML; Kindelan, J; Bennett, RL; Reiner, AP; Cote, HCF
    Fibrinogen Bellingham: A gamma-chain R275C substitution and a beta-promoter polymorphism in a thrombotic member of an asymptomatic family
    AMERICAN JOURNAL OF HEMATOLOGY
    
    M.L. Linenberger et al., "Fibrinogen Bellingham: A gamma-chain R275C substitution and a beta-promoter polymorphism in a thrombotic member of an asymptomatic family", AM J HEMAT, 64(4), 2000, pp. 242-250
59. Nakasaki, T; Wada, H; Mori, Y; Okugawa, Y; Watanabe, R; Nishikawa, M; Gabazza, EC; Masuya, M; Kageyama, S; Kumeda, K; Kato, H; Shiku, H
    Decreased tissue factor and tissue-plasminogen activator antigen in relapsed acute promyelocytic leukemia
    AMERICAN JOURNAL OF HEMATOLOGY
    
    T. Nakasaki et al., "Decreased tissue factor and tissue-plasminogen activator antigen in relapsed acute promyelocytic leukemia", AM J HEMAT, 64(3), 2000, pp. 145-150
60. Leng, HMJ; Brouwers, E; Knockaert, I; Declerck, PJ
    Immunoassays for the quantitation of porcine PAI-1 antigen and activity inbiological fluid samples
    THROMBOSIS AND HAEMOSTASIS
    
    H.M.J. Leng et al., "Immunoassays for the quantitation of porcine PAI-1 antigen and activity inbiological fluid samples", THROMB HAEM, 84(6), 2000, pp. 1082-1086
61. Sjogren, LS; Gan, LM; Doroudi, R; Jern, C; Jungersten, L; Jern, S
    Fluid shear stress increases the intra-cellular storage pool of tissue-type plasminogen activator in intact human conduit vessels
    THROMBOSIS AND HAEMOSTASIS
    
    L.S. Sjogren et al., "Fluid shear stress increases the intra-cellular storage pool of tissue-type plasminogen activator in intact human conduit vessels", THROMB HAEM, 84(2), 2000, pp. 291-298
62. Gunther, A; Mosavi, P; Ruppert, C; Heinemann, S; Temmesfeld, B; Velcovsky, HG; Morr, H; Grimminger, F; Walmrath, D; Seeger, W
    Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease
    THROMBOSIS AND HAEMOSTASIS
    
    A. Gunther et al., "Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease", THROMB HAEM, 83(6), 2000, pp. 853-860
63. Camani, C; Gavin, O; Kruithof, EKO
    Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator - Requirement for a co-receptor?
    THROMBOSIS AND HAEMOSTASIS
    
    C. Camani et al., "Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator - Requirement for a co-receptor?", THROMB HAEM, 83(2), 2000, pp. 290-296
64. Chandler, WL; Alessi, MC; Aillaud, MF; Vague, P; Juhan-Vague, I
    Formation, inhibition and clearance of plasmin in vivo
    HAEMOSTASIS
    
    W.L. Chandler et al., "Formation, inhibition and clearance of plasmin in vivo", HAEMOSTASIS, 30(4), 2000, pp. 204-218
65. Vivien, D; Buisson, A
    Serine protease inhibitors: Novel therapeutic targets for stroke?
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    
    D. Vivien e A. Buisson, "Serine protease inhibitors: Novel therapeutic targets for stroke?", J CEREBR B, 20(5), 2000, pp. 755-764
66. Tabengwa, EM; Abou-Agag, LH; Benza, RL; Torres, JA; Aikens, ML; Booyse, FM
    Ethanol-induced up-regulation of candidate plasminogen receptor annexin IIin cultured human endothelial cells
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    
    E.M. Tabengwa et al., "Ethanol-induced up-regulation of candidate plasminogen receptor annexin IIin cultured human endothelial cells", ALC CLIN EX, 24(6), 2000, pp. 754-761
67. Yarzabal, A; Avilan, L; Hoelzl, K; de Munoz, M; Puig, J; Kansau, I
    A study of the interaction between Helicobacter pylori and components of the human fibrinolytic system
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    
    A. Yarzabal et al., "A study of the interaction between Helicobacter pylori and components of the human fibrinolytic system", BRAZ J MED, 33(9), 2000, pp. 1015-1021
68. Nagaoka, MR; Kouyoumdjian, M; Borges, DR
    The hepatic clearance of recombinant tissue-type plasminogen activator decreases after an inflammatory stimulus
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    
    M.R. Nagaoka et al., "The hepatic clearance of recombinant tissue-type plasminogen activator decreases after an inflammatory stimulus", BRAZ J MED, 33(1), 2000, pp. 119-125
69. Katzan, IL; Furlan, AJ; Lloyd, LE; Frank, JI; Harper, DL; Hinchey, JA; Hammel, JP; Qu, A; Sila, CA
    Use of tissue-type plasminogen activator for acute ischemic stroke - The Cleveland area experience
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    
    I.L. Katzan et al., "Use of tissue-type plasminogen activator for acute ischemic stroke - The Cleveland area experience", J AM MED A, 283(9), 2000, pp. 1151-1158
70. Fukao, H; Matsuo, O
    Antithrombotic regulation in human endothelial cells by fibrinolytic factors
    SEMINARS IN THROMBOSIS AND HEMOSTASIS
    
    H. Fukao e O. Matsuo, "Antithrombotic regulation in human endothelial cells by fibrinolytic factors", SEM THROMB, 26(1), 2000, pp. 33-38
71. Ieko, M; Ichikawa, K; Atsumi, T; Takeuchi, R; Sawada, KI; Yasukouchi, T; Koike, T
    Effects of beta 2-glycoprotein I and monoclonal anticardiolipin antibodieson extrinsic fibrinolysis
    SEMINARS IN THROMBOSIS AND HEMOSTASIS
    
    M. Ieko et al., "Effects of beta 2-glycoprotein I and monoclonal anticardiolipin antibodieson extrinsic fibrinolysis", SEM THROMB, 26(1), 2000, pp. 85-90
72. Oikawa, K; Watanabe, T; Miyamoto, I; Higuchi, S
    Determination, pharmacokinetics and protein binding of a novel tissue-typeplasminogen activator, pamiteplase in human plasma
    XENOBIOTICA
    
    K. Oikawa et al., "Determination, pharmacokinetics and protein binding of a novel tissue-typeplasminogen activator, pamiteplase in human plasma", XENOBIOTICA, 30(10), 2000, pp. 993-1003
73. Hooper, WC; Lally, C; Austin, H; Renshaw, M; Dilley, A; Wenger, NK; Phillips, DJ; Whitsett, C; Rawlins, P; Evatt, BL
    The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-Americanadults with a diagnosis of myocardial infarction or venous thromboembolism
    THROMBOSIS RESEARCH
    
    W.C. Hooper et al., "The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-Americanadults with a diagnosis of myocardial infarction or venous thromboembolism", THROMB RES, 99(3), 2000, pp. 223-230
74. Prisco, D; Paniccia, R; Bandinelli, B
    Effect of temperature and incubation time on D-dimer serum levels in healthy subjects
    THROMBOSIS RESEARCH
    
    D. Prisco et al., "Effect of temperature and incubation time on D-dimer serum levels in healthy subjects", THROMB RES, 97(6), 2000, pp. 513-517
75. Huber, K
    Increase of efficacy of thrombolytic therapy in acute myocardial infarction by improvement of the characteristics of new fibrinolytic agents
    WIENER KLINISCHE WOCHENSCHRIFT
    
    K. Huber, "Increase of efficacy of thrombolytic therapy in acute myocardial infarction by improvement of the characteristics of new fibrinolytic agents", WIEN KLIN W, 112(17), 2000, pp. 742-748
76. Ruibal, A; Arias, JI; del Rio, MC; San Roman, JM; Lapena, G; Schneider, J; Tejerina, A
    The cytosolic hyaluronic acid level defines some clinical-biological properties of CD44v5-positive infiltrating ductal carcinomas of the breast
    MEDICINA CLINICA
    
    A. Ruibal et al., "The cytosolic hyaluronic acid level defines some clinical-biological properties of CD44v5-positive infiltrating ductal carcinomas of the breast", MED CLIN, 115(6), 2000, pp. 205-207
77. Fukao, H; Ueshima, S; Okada, K; Matsuo, O
    Binding of mutant tissue-type plasminogen activators to human endothelial cells and their extracellular matrix
    LIFE SCIENCES
    
    H. Fukao et al., "Binding of mutant tissue-type plasminogen activators to human endothelial cells and their extracellular matrix", LIFE SCI, 66(25), 2000, pp. 2473-2487
78. Bolliger-Stucki, B; Baillod, P; Mader, W; Furlan, M
    Biochemical properties of the fibrinogen component of a fibrin glue beforeand after severe dry heat treatment
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
    
    B. Bolliger-Stucki et al., "Biochemical properties of the fibrinogen component of a fibrin glue beforeand after severe dry heat treatment", J BIOMED MR, 53(5), 2000, pp. 577-583
79. Goldfinger, LE; Jiang, LH; Hopkinson, SB; Stack, MS; Jones, JCR
    Spatial regulation and activity modulation of plasmin by high affinity binding to the G domain of the alpha(3) subunit of laminin-5
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    L.E. Goldfinger et al., "Spatial regulation and activity modulation of plasmin by high affinity binding to the G domain of the alpha(3) subunit of laminin-5", J BIOL CHEM, 275(45), 2000, pp. 34887-34893
80. Rutanen, EM; Hurskainen, R; Finne, P; Nokalainen, K
    Induction of endometrial plasminogen activator-inhibitor 1: a possible mechanism contributing to the effect of intrauterine levonorgestrel in the treatment of menorrhagia
    FERTILITY AND STERILITY
    
    E.M. Rutanen et al., "Induction of endometrial plasminogen activator-inhibitor 1: a possible mechanism contributing to the effect of intrauterine levonorgestrel in the treatment of menorrhagia", FERT STERIL, 73(5), 2000, pp. 1020-1024
81. Costa, M; Shen, Y; Medcalf, RL
    Overexpression of a dominant negative CREB protein in HT-1080 cells selectively disrupts plasminogen activator inhibitor type 2 but not tissue-type plasminogen activator gene expression
    FEBS LETTERS
    
    M. Costa et al., "Overexpression of a dominant negative CREB protein in HT-1080 cells selectively disrupts plasminogen activator inhibitor type 2 but not tissue-type plasminogen activator gene expression", FEBS LETTER, 482(1-2), 2000, pp. 75-80
82. Kruszynska, YT; Yu, JG; Olefsky, JM; Sobel, BE
    Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects
    DIABETES
    
    Y.T. Kruszynska et al., "Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects", DIABETES, 49(4), 2000, pp. 633-639
83. Chandler, WL; Jascur, ML; Henderson, PJ
    Measurement of different forms of tissue plasminogen activator in plasma
    CLINICAL CHEMISTRY
    
    W.L. Chandler et al., "Measurement of different forms of tissue plasminogen activator in plasma", CLIN CHEM, 46(1), 2000, pp. 38-46
84. Labinjoh, C; Newby, DE; Dawson, P; Johnston, NR; Ludlam, CA; Boon, NA; Webb, DJ
    Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in man
    CARDIOVASCULAR RESEARCH
    
    C. Labinjoh et al., "Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in man", CARDIO RES, 47(4), 2000, pp. 707-714
85. Cugno, M; Dominguez, M; Cabibbe, M; Bisiani, G; Galli, M; Angles-Cano, E; Agostoni, A
    Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome
    BRITISH JOURNAL OF HAEMATOLOGY
    
    M. Cugno et al., "Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome", BR J HAEM, 108(4), 2000, pp. 871-875
86. Kawasaki, T; Dewerchin, M; Lijnen, HR; Vermylen, J; Hoylaerts, MF
    Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysisduring acute arterial thrombosis in mice
    BLOOD
    
    T. Kawasaki et al., "Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysisduring acute arterial thrombosis in mice", BLOOD, 96(1), 2000, pp. 153-160
87. Fann, CH; Guirgis, F; Chen, G; Lao, MS; Piret, JM
    Limitations to the amplification and stability of human tissue-type plasminogen activator expression by Chinese hamster ovary cells
    BIOTECHNOLOGY AND BIOENGINEERING
    
    C.H. Fann et al., "Limitations to the amplification and stability of human tissue-type plasminogen activator expression by Chinese hamster ovary cells", BIOTECH BIO, 69(2), 2000, pp. 204-212
88. Yakovlev, S; Makogonenko, E; Kurochkina, N; Nieuwenhuizen, W; Ingham, K; Medved, L
    Conversion of fibrinogen to fibrin: Mechanism of exposure of tPA- and plasminogen-binding sites
    BIOCHEMISTRY
    
    S. Yakovlev et al., "Conversion of fibrinogen to fibrin: Mechanism of exposure of tPA- and plasminogen-binding sites", BIOCHEM, 39(51), 2000, pp. 15730-15741
89. Fitzpatrick, SL; Kassam, G; Choi, KS; Kang, HM; Fogg, DK; Waisman, DM
    Regulation of plasmin activity by annexin II tetramer
    BIOCHEMISTRY
    
    S.L. Fitzpatrick et al., "Regulation of plasmin activity by annexin II tetramer", BIOCHEM, 39(5), 2000, pp. 1021-1028
90. Verstraete, M
    Third-generation thrombolytic drugs
    AMERICAN JOURNAL OF MEDICINE
    
    M. Verstraete, "Third-generation thrombolytic drugs", AM J MED, 109(1), 2000, pp. 52-58
91. Ioannidou-Papayannaki, E; Lefkos, N; Boudonas, G; Efthimiadis, A; Psirropoulos, D; Vogas, V; Papadopoulos, I; Klonizakis, I
    Alterations in the fibrinolytic system components during acute myocardial infarction
    ACTA CARDIOLOGICA
    
    E. Ioannidou-Papayannaki et al., "Alterations in the fibrinolytic system components during acute myocardial infarction", ACT CARDIOL, 55(4), 2000, pp. 247-253
92. Booth, NA
    Fibrinolysis and thrombosis
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    
    N.A. Booth, "Fibrinolysis and thrombosis", BEST P R C, 12(3), 1999, pp. 423-433
93. Holmberg, A; Westman, B; Bergqvist, D; Siegbahn, A
    Fibrinolysis in open abdominal aortic aneurysm surgery
    FIBRINOLYSIS & PROTEOLYSIS
    
    A. Holmberg et al., "Fibrinolysis in open abdominal aortic aneurysm surgery", FIBRINOL PR, 13(4-5), 1999, pp. 155-162
94. Newby, DE; Strachan, FE; Johnston, NR; Webb, DJ
    Endothelin-1 does not contribute to the release of tissue plasminogen activator in vivo in man
    FIBRINOLYSIS & PROTEOLYSIS
    
    D.E. Newby et al., "Endothelin-1 does not contribute to the release of tissue plasminogen activator in vivo in man", FIBRINOL PR, 13(4-5), 1999, pp. 185-191
95. Smith, BJ
    Thrombolysis in acute myocardial infarction: analysis of studies comparingaccelerated t-PA and streptokinase
    JOURNAL OF ACCIDENT & EMERGENCY MEDICINE
    
    B.J. Smith, "Thrombolysis in acute myocardial infarction: analysis of studies comparingaccelerated t-PA and streptokinase", J AC EMER M, 16(6), 1999, pp. 407-411
96. Siu, YCA; Wong, TW; Lau, CC
    Candidates for thrombolytic treatment in acute ischaemic stroke - where are our patients in Hong Kong?
    JOURNAL OF ACCIDENT & EMERGENCY MEDICINE
    
    Y.C.A. Siu et al., "Candidates for thrombolytic treatment in acute ischaemic stroke - where are our patients in Hong Kong?", J AC EMER M, 16(6), 1999, pp. 412-417
97. Tjarnstrom, J; Holmdahl, L; Arnell, P; Falkenberg, M; Risberg, B
    Treatment with hyperbaric oxygen affects endothelial cell fibrinolysis
    EUROPEAN JOURNAL OF SURGERY
    
    J. Tjarnstrom et al., "Treatment with hyperbaric oxygen affects endothelial cell fibrinolysis", EURO J SURG, 165(9), 1999, pp. 834-838
98. Rosnoblet, C; Vischer, UM; Gerard, RD; Irminger, JC; Halban, PA; Kruithof, EKO
    Storage of tissue-type plasminogen activator in Weibel-Palade bodies of human endothelial cells
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    C. Rosnoblet et al., "Storage of tissue-type plasminogen activator in Weibel-Palade bodies of human endothelial cells", ART THROM V, 19(7), 1999, pp. 1796-1803
99. Yamada, R; Ueno, S; Ishii, A; Yamada, S
    Idiopathic central serous chorioretinopathy: Promoting factors
    ANNALS OF OPHTHALMOLOGY & GLAUCOMA
    
    R. Yamada et al., "Idiopathic central serous chorioretinopathy: Promoting factors", ANN OPHTH G, 31(2), 1999, pp. 85-90
100. Kang, HM; Choi, KS; Kassam, G; Fitzpatrick, SL; Kwon, M; Waisman, DM
     Role of annexin II tetramer in plasminogen activation
     TRENDS IN CARDIOVASCULAR MEDICINE
     
     H.M. Kang et al., "Role of annexin II tetramer in plasminogen activation", TREND CARD, 9(3-4), 1999, pp. 92-102